Surgeons have begun to transition total shoulder arthroplasty (TSA) to the outpatient setting in order to contain costs and reallocate resources.
Purpose:
The purpose of this systematic review was to evaluate the safety and cost of outpatient TSA by assessing associated complication rates, clinical outcomes, and total treatment charges.
Methods:
The MEDLINE, Embase, and Cochrane Library online databases were queried in March 2020 for studies on outpatient shoulder arthroplasty. Inclusion criteria were (1) a study population undergoing TSA, (2) discharge on the day of surgery, and (3) inclusion of at least 1 reported outcome.
Results:
Of 20 studies identified that met inclusion criteria, 14 were comparative studies involving an inpatient control group, 2 of which were matched by age and comorbidities. The remaining studies used control groups consisting of inpatient TSAs who were older or more medically infirm according to American Society of Anesthesiologists (ASA) or Charlson Comorbidity Index (CCI) scores. The combined average age of the outpatient and inpatient groups was 66.5 and 70.1 years, respectively. Patients who underwent outpatient TSA had similar rates of readmissions, emergency department visits, and perioperative complications in comparison to inpatients. Patients also reported comparably high levels of satisfaction with outpatient procedures. Four economic analyses demonstrated substantial cost savings with outpatient TSA in comparison to inpatient surgery.
Conclusion:
In carefully selected patients, outpatient TSA appears to be equally safe but less resource intensive than inpatient arthroplasty. Nonetheless, there remains a need for larger prospective studies to decisively characterize the relative safety of outpatient TSA among patients with similar baseline health.
AbildgaardJTLonerganKTTolanSJ, et al. Liposomal bupivacaine versus indwelling interscalene nerve block for postoperative pain control in shoulder arthroplasty: a prospective randomized controlled trial. J Shoulder Elb Surg. 2017;26:1175–1181.
2.
AnthonyCAWestermannRWGaoY, et al. What are risk factors for 30-day morbidity and transfusion in total shoulder arthroplasty? A review of 1922 cases. Clin Orthop Relat Res. 2015;473:2099–2105.
3.
ArshiALeongNLWangC, et al. Relative complications and trends of outpatient total shoulder arthroplasty. Orthopedics. 2018;41:E400–E409.
4.
AynardiMPostZOngA, et al. Outpatient surgery as a means of cost reduction in total hip arthroplasty: a case-control study. HSS J. 2014;10:252–255.
5.
BanghuMMutterTDubberleyJ, et al. Single-injection interscalene bupivacaine and dexamethasone for same-day discharge total shoulder arthroplasty: a case series. Can J Anaesth. 2017;64:435–437.
6.
BasquesBAEricksonBJLerouxT, et al. Comparative outcomes of outpatient and inpatient total shoulder arthroplasty. Bone Jt J. 2017;99B:934–938.
7.
BeanBAConnorPMSchiffernSCHamidN.Outpatient shoulder arthroplasty at an ambulatory surgery center using a multimodal pain management approach. J Am Acad Orthop Surg Glob Res Rev. 2018;2:e064.
8.
BergerRAKusumaSKSandersSAThillESSporerSM.The feasibility and perioperative complications of outpatient knee arthroplasty. Clin Orthop Rel Res. 2009;467:1443–1449.
9.
BergerRASandersSAD’AmbrogioE, et al. Minimally invasive quadriceps-sparing TKA: results of a comprehensive pathway for outpatient TKA. J Knee Surg. 2006;19:145–148.
10.
BergerRASandersSAThillESSporerSMDella ValleC.Newer anesthesia and rehabilitation protocols enable outpatient hip replacement in selected patients. Clin Orthop Relat Res. 2009;467:1424–1430.
11.
BertinKC.Minimally invasive outpatient total hip arthroplasty: a financial analysis. Clin Orthop Relat Res. 2005;435:154–163.
12.
BrolinTJCoxRMZmistowskiBMNamdariSWilliamsGRAbboudJA.Surgeons’ experience and perceived barriers with outpatient shoulder arthroplasty. J Shoulder Elb Surg. 2018;27:S82–S87.
13.
BrolinTJMulliganRPAzarFMThrockmortonT.Neer Award 2016: outpatient total shoulder arthroplasty in an ambulatory surgery center is a safe alternative to inpatient total shoulder arthroplasty in a hospital: a matched cohort study. J Shoulder Elb Surg. 2017;26:204–208.
14.
CancienneJMBrockmeierSFGulottaLVDinesDMWernerBC.Ambulatory total shoulder arthroplasty: a comprehensive analysis of current trends, complications, readmissions, and costs. J Bone Joint Surg Am. 2017;99:629–637.
15.
CharlesMDCvetanovichGSumner-ParillaSNicholsonGPVermaNRomeoAA.Outpatient shoulder arthroplasty: outcomes, complications, and readmissions in 2 outpatient settings. J Shoulder Elb Surg. 2019;28:S118–S123.
16.
CrawfordDCLiCSSpragueSBhandariM.Clinical and cost implications of inpatient versus outpatient orthopedic surgeries: a systematic review of the published literature. Orthop Rev. 2015;7:116–121.
17.
CrossMBBergerR.Feasibility and safety of performing outpatient unicompartmental knee arthroplasty. Int Orthop. 2014;38:443–447.
18.
CvetanovichGLFillinghamYAO’BrienM, et al. Tranexamic acid reduces blood loss after primary shoulder arthroplasty: a double-blind, placebo-controlled, prospective, randomized controlled trial. JSES Open Access. 2018;2:23–27.
19.
DayJSLauEOngKLWilliamsGRRamseyMLKurtzSM.Prevalence and projections of total shoulder and elbow arthroplasty in the United States to 2015. J Shoulder Elb Surg. 2010;19:1115–1120.
DillonMTChanPHInacioMCSSinghAYianEHNavarroRA.Yearly trends in elective shoulder arthroplasty, 2005–2013. Arthritis Care Res. 2017;69:1574–1581.
22.
DorrLDThomasDJZhuJDastaneMChaoLLongWT.Outpatient total hip arthroplasty. J Arthroplasty. 2010;25:501–506.
23.
DunnJCLanziJKusnezovNBaderJWatermanBRBelmontPJ.Predictors of length of stay after elective total shoulder arthroplasty in the United States. J Shoulder Elb Surg. 2015;24:754–759.
24.
EricksonBJShishaniYJonesS, et al. Outpatient vs. inpatient reverse total shoulder arthroplasty: outcomes and complications. J Shoulder Elb Surg. 2020;29:1115–1120. https://doi.org/10.1016/j.jse.2019.10.023.
25.
FarmerKWHammondJWQuealeWSKeyurapanEMcFarlandEG.Shoulder arthroplasty versus hip and knee arthroplasties: a comparison of outcomes. Clin Orthop Relat Res. 2007;455:183–189.
26.
FehringerEVMikulsTRMichaudKDHendersonWGO’DellJR.Shoulder arthroplasties have fewer complications than hip or knee arthroplasties in US veterans. Clin Orthop Relat Res. 2010;468:717–722.
27.
FournierMNBrolinTJAzarFMStephensRThrockmortonTW.Identifying appropriate candidates for ambulatory outpatient shoulder arthroplasty: validation of a patient selection algorithm. J Shoulder Elb Surg. 2019;28:65–70.
28.
FriedmanRJGordonEButlerRBMockLDumasB.Tranexamic acid decreases blood loss after total shoulder arthroplasty. J Shoulder Elb Surg. 2016;25:614–618.
29.
GallaySHLoboJJABakerJSmithKPatelK.Development of a regional model of care for ambulatory total shoulder arthroplasty: a pilot study. Clin Orthop Rel Res. 2008;466:563–572.
30.
GillespieRShishaniYJosephSStreitJJGobezieR.Neer Award 2015: a randomized, prospective evaluation on the effectiveness of tranexamic acid in reducing blood loss after total shoulder arthroplasty. J Shoulder Elb Surg. 2015;24:1679–1684.
31.
GonduskyJSChoiLKhalafNPatelJBarnettSGorabR.Day of surgery discharge after unicompartmental knee arthroplasty: an effective perioperative pathway. J Arthroplasty. 2014;29:516–519.
32.
GregoryJMWetzigAMWayneCDBaileyLWarthRJ.Quantification of patient-level costs in outpatient total shoulder arthroplasty. J Shoulder Elb Surg. 2019;28:1066–1073.
33.
HarjulaJNEPalonevaJHaapakoskiJKukkonenJÄärimaaV. Increasing incidence of primary shoulder arthroplasty in Finland: a nationwide registry study. BMC Musculoskelet Disord. 2018;19:245.
34.
HollingsworthJMYeZStropeSAKreinSLHollenbeckATHollenbeckBK.Physician-ownership of ambulatory surgery centers linked to higher volume of surgeries. Health Aff. 2010;29:683–689.
35.
IlfeldBMVandenborneKDuncanPW, et al. Ambulatory continuous interscalene nerve blocks decrease the time to discharge readiness after total shoulder arthroplasty: a randomized, triple-masked, placebo-controlled study. Anesthesiology. 2006;105:999–1007.
36.
IlfeldBMWrightTWEnnekingFK, et al. Total shoulder arthroplasty as an outpatient procedure using ambulatory perineural local anesthetic infusion: a pilot feasibility study. Anesth Analg. 2005;101:1319–1322.
JainNBHigginsLDGullerUPietrobonRKatzJN.Trends in the epidemiology of total shoulder arthroplasty in the United States from 1990-2000. Arthritis Care Res. 2006;55:591–597.
39.
KimSHWiseBLZhangYSzaboR.Increasing incidence of shoulder arthroplasty in the United States. J Bone Jt Surg Am. 2011;93:2249–2254.
40.
KolisekFRMcGrathMSJessupNMMonesmithEAMontMA.Comparison of outpatient versus inpatient total knee arthroplasty. Clin Orthop Rel Res. 2009;467:1438–1442.
41.
KramerJDChanPHPrenticeHAHatchJDillonMTNavarroRA.Same-day discharge is not inferior to longer length of in-hospital stay for 90-day readmissions following shoulder arthroplasty. J Shoulder Elb Surg. 2020;29:898–905.
42.
LerouxTSBasquesBAFrankRM, et al. Outpatient total shoulder arthroplasty: a population-based study comparing adverse event and readmission rates to inpatient total shoulder arthroplasty. J Shoulder Elb Surg. 2016;25:1780–1786.
43.
LerouxTSZukeWASaltzmanBM, et al. Safety and patient satisfaction of outpatient shoulder arthroplasty. JSES Open Access. 2018;2:13–17.
44.
LovaldSTOngKLLauEJoshiGKurtzSMalkaniA.Patient selection in outpatient and short-stay total knee arthroplasty. J Surg Orthop Adv. 2014;23:2–8.
45.
LovaldSTOngKLMalkaniAL, et al. Complications, mortality, and costs for outpatient and short-stay total knee arthroplasty patients in comparison to standard-stay patients. J Arthroplasty. 2014;29:510–515.
46.
MeneghiniRMZiemba-DavisMIshmaelMKKuzmaALCaccavalloP. Safe selection of outpatient joint arthroplasty patients with medical risk stratification: the “outpatient arthroplasty risk assessment score.”J Arthroplasty. 2017;32:2325–2331.
MoherDLiberatiATetzlaffJAltmanDG.Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6; e1000097. https://doi.org/10.1371/journal.pmed.1000097.
49.
NamdariSNicholsonTAbboudJLazarusMSteinbergDWilliamsG.Interscalene block with and without intraoperative local infiltration with liposomal bupivacaine in shoulder arthroplasty: a randomized controlled trial. J Bone Jt Surg Am. 2018;100:1373–1378.
50.
NelsonCGMurphyWGMulliganRPBrolinTJAzarFMThrockmortonTW.A retrospective comparative study of patient satisfaction following ambulatory outpatient and inpatient total shoulder arthroplasty. Curr Orthop Pract. 2019;30:435–438.
51.
NwankwoCDDuttonPMerrimanJAGajudoGGillKHatchJ.Outpatient total shoulder arthroplasty does not increase the 90-day risk of complications compared with inpatient surgery in prescreened patients. Orthopedics. 2018;41:e563–e568.
52.
OdeGEOdumSConnorPMHamidN.Ambulatory versus inpatient shoulder arthroplasty: a population-based analysis of trends, outcomes, and charges. JSES Int. 2020;4:127–132.
53.
OkorohaKRLynchJRKellerRA, et al. Liposomal bupivacaine versus interscalene nerve block for pain control after shoulder arthroplasty: a prospective randomized trial. J Shoulder Elb Surg. 2016;25:1742–1748.
54.
PadegimasEMMaltenfortMLazarusMDRamseyMLWilliamsGRNamdariS.Future patient demand for shoulder arthroplasty by younger patients: national projections. Clin Orthop Relat Res. 2015;473:1860–1867.
55.
PollockMSomervilleLFirthALantingB.Outpatient total hip arthroplasty, total knee arthroplasty, and unicompartmental knee arthroplasty: a systematic review of the literature. JBJS Rev. 2016;4(12):e4.https://doi.org/10.2106/JBJS.RVW.16.00002.
56.
RasmussenJVAmundsenABelling SørensenAK, et al. Increased use of total shoulder arthroplasty and improved patient-reported outcome for osteoarthritic patient in Denmark from 2006 to 2015: a nationwide cohort study from the Danish Shoulder Arthroplasty Registry. JSES Open Access. 2019;3:245.
57.
SabesanVJShahriarRPetersen-FittsGR, et al. A prospective randomized controlled trial to identify the optimal postoperative pain management in shoulder arthroplasty: liposomal bupivacaine versus continuous interscalene catheter. J Shoulder Elb Surg. 2017;26:1810–1817.
58.
SteinhausMEShimSSLambaNMakhniECKadiyalaRK.Outpatient total shoulder arthroplasty: a cost-identification analysis. J Orthop. 2018;15:581–585.
59.
WaltersJDWalshRNSmithRABrolinTJAzarFMThrockmortonTW.Bundled payment plans are associated with notable cost savings for ambulatory outpatient total shoulder arthroplasty. J Am Acad Orthop Surg. 2019;28:795–801.
60.
WellerWJAzzamMGSmithRAAzarFMThrockmortonTW.Liposomal bupivacaine mixture has similar pain relief and significantly fewer complications at less cost compared to indwelling interscalene catheter in total shoulder arthroplasty. J Arthroplasty. 2017;32:3557–3562.
61.
WilliamsGNGangelTJArcieroRAUhorchakJMTaylorDC.Comparison of the single assessment numeric evaluation method and two shoulder rating scales. Outcomes measures after shoulder surgery. Am J Sports Med. 1999;27:214–221.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
